Patents Assigned to Ajinomoto Company, Inc.
-
Patent number: 5728863Abstract: Wet crystals of .alpha.-L-aspartyl-L-phenylalanine methyl ester with low water content can be obtained with high efficiency by solid-liquid separation of an aqueous suspension of .alpha.-L-aspartyl-L-phenylalanine methyl ester. The aqueous suspension is compressed at a final pressure of at least 20 kg/cm.sup.2 as a bearing pressure, and the wet crystals are dried after compression.Type: GrantFiled: February 15, 1996Date of Patent: March 17, 1998Assignee: Ajinomoto Company, Inc.Inventors: Takehiko Kataoka, Shinichi Kishimoto, Osahiro Sato
-
Patent number: 5705370Abstract: Culturing an L-amino acid producing microorganism belonging to the genus Brevibacterium or Corynebacterium and having a resistance to a peptide containing glutamic acid or aspartic acid gives L-amino acids in high yield.Type: GrantFiled: May 12, 1995Date of Patent: January 6, 1998Assignee: Ajinomoto Company, Inc.Inventors: Takayasu Tsuchida, Haruo Uchibori, Hiroshi Takeuchi, Mitsuyoshi Seki
-
Patent number: 5540924Abstract: A composition for the prevention and treatment of diarrhea in animals, containing sterilized cells of bacteria belonging to the genus Bacillus, Brevibacterium, Corynebacterium, Escherichia, Lactobacillus, Streptococcus, or Streptomyces, a cell homogenate of said sterilized cells, a cell wall component-containing fraction of said homogenate or mixtures thereof. These ingredients of the composition are admixed into an animal feed.Type: GrantFiled: July 22, 1994Date of Patent: July 30, 1996Assignee: Ajinomoto Company, Inc.Inventors: Norimasa Onishi, Akihiro Yamashiro
-
Patent number: 5473097Abstract: Granules of .alpha.-L-aspartyl-L-phenylalanine methyl ester, containing IB crystals of the ester and having a grain size of from 100 to 1400 .mu.m have improved water solubility.Type: GrantFiled: October 1, 1993Date of Patent: December 5, 1995Assignee: Ajinomoto Company, Inc.Inventors: Shinichi Kishimoto, Akihiko Yasaki
-
Patent number: 5372810Abstract: A composition and method for the prevention and treatment of diarrhea in domesticated animals, comprising sterilized cells of aerobic bacteria belonging to the genus Bacillus, Brevibacterium, Corynebacterium, Escherichia, Lactobacillus, Streptococcus, or Streptomyces, a cell homogenate of said sterilized cells, a cell wall component-containing fraction of said homogenate or mixtures thereof. In particular species of Corynebacterium glutamicum and Brevibacterium lactofermentum as well as strains thereof, such as A.T.C.C. 13060 and A.T.C.C. 13869, respectively, are useful in the treatment of diarrhea in domesticated animals.Type: GrantFiled: November 9, 1992Date of Patent: December 13, 1994Assignee: Ajinomoto Company, Inc.Inventors: Norimasa Onishi, Akihiro Yamashiro
-
Patent number: 5294547Abstract: Culturing an L-amino acid producing microorganism belonging to the genus Brevibacterium or corynebacterium and having a resistance to a dipeptide containing glutamic acid or aspartic acid gives L-amino acids in high yield.Type: GrantFiled: September 6, 1991Date of Patent: March 15, 1994Assignee: Ajinomoto Company, Inc.Inventors: Takayasu Tsuchida, Haruo Uchibori, Hiroshi Takeuchi, Mitsuyoshi Seki
-
Patent number: 5292757Abstract: 1,4-dihydropyridine derivatives of Formula 1 or pharmaceutically acceptable salts thereof: ##STR1## wherein the substituents are disclosed herein and which are useful against tumor cells which have acquired resistance to one or more drugs used as chemotherapeutic agents.Type: GrantFiled: April 24, 1992Date of Patent: March 8, 1994Assignee: Ajinomoto Company, Inc.Inventors: Koji Ohsumi, Takaaki Sekiyama, Ryusuke Nakagawa, Takashi Tsuji, Yoshihiro Morinaga, Kazuo Ohishi
-
Patent number: 5284757Abstract: L-arginine is produced in high yields by culturing a microorganism of the genus Brevibacterium or the genus Cornyebacterium, which is resistant to a compound of the formula X-guanidine, wherein X is an aliphatic group or derivative thereof. The preferred microorganisms are Brevibacterium flavum FERM BP-2227 and Corynebacterium glutamicum FERM BP-2228.Type: GrantFiled: April 23, 1993Date of Patent: February 8, 1994Assignee: Ajinomoto Company, Inc.Inventors: Takayasu Tsuchida, Noboro Ohtsuka, Hiroshi Takeuchi, Haruo Uchibori
-
Patent number: 5244661Abstract: By irradiating a polyene antibiotic having a cis-type polyene structure with long wavelength ultraviolet light, it is possible to prepare the corresponding antibiotic having a trans-type polyene structure in high yield in a simple manner. Such antibiotics having a trans-type polyene structure exhibit strong antimicrobial activities and are useful as drugs for humans or animals.Type: GrantFiled: April 26, 1990Date of Patent: September 14, 1993Assignee: Ajinomoto Company, Inc.Inventors: Koichi Ishii, Shigeyoshi Miyashiro
-
Patent number: 5206160Abstract: A cleavage promoting agent comprising as an effective ingredient at least one of the polypeptides BUF-3, BUF-4 and BUF-5 is useful for the treatment of fertilized or unfertilized ova in order to promote cell division and improve reproduction efficiency.Type: GrantFiled: September 11, 1990Date of Patent: April 27, 1993Assignees: Ajinomoto Company, Inc., Michio TakahashiInventors: Michio Takahashi, Kunio Shioda, Hiroshiro Shibai
-
Patent number: 5200395Abstract: The polypeptides BUF-4 and BUF-5 may be used to treat osteoporosis, cancer, and anemia, and pharmaceutical compositions containing BUF-4 and/or BUF-5 are disclosed.Type: GrantFiled: October 29, 1991Date of Patent: April 6, 1993Assignee: Ajinomoto Company, Inc.Inventors: Yuzuru Eto, Naoto Koyama, Daisuke Ejima, Masayo Washitake, Hiroshiro Shibai
-
Patent number: 5185327Abstract: A new glucan derivative having at least one side chain branch of a compound selected from the group consisting of galactopyranose, L-arabinofuranose and oligomers thereof is disclosed. These glucan derivatives have high tumoricidal activity and are usable as a tumoricide.Type: GrantFiled: August 24, 1990Date of Patent: February 9, 1993Assignee: Ajinomoto Company, Inc.Inventors: Kei Matsuzaki, Iwao Yamamoto, Akira Misaki, Yoshiaki Sone
-
Patent number: 5116631Abstract: Low-calorie foods containing konjak mannan, such as meringues and mayonnaise-like foods, and processes for preparing such foods are disclosed.Type: GrantFiled: January 23, 1991Date of Patent: May 26, 1992Assignee: Ajinomoto Company, Inc.Inventors: Jiro Sakamoto, Hiromi Tanuma
-
Patent number: 5074959Abstract: A complex of fibrous material and fungi is prepared by allowing fungi to grow in a medium containing a fibrous material.Type: GrantFiled: February 7, 1990Date of Patent: December 24, 1991Assignee: Ajinomoto Company, Inc.Inventors: Shigeru Yamanaka, Reiko Kikuchi
-
Patent number: 5070208Abstract: Optically active tryptophan is crystallized by a modification of a method of crystrallization of optically active tryptophan through neutralization by mixing an acidic or alkaline aqueous solution of optically active tryptophan, which is obtained by the removal of impurities from an acidic or alkaline aqueous solution of optically active tryptophan containing impurities which inhibit flocculation and crystallization of optically active tryptophan, with an alkali or an acid, by combining portions of an alkali or acid with portions of an acidic or alkaline aqueous solution of optically active tryptophan, from which the impurities have been removed, thereby neutralizing the aqueous solution containing optically active tryptophan such that the pH of the solution to be crystallized is kept in a range of 3 to 8, and simultaneously crystallizing optically active tryptophan as flocculated crystals.Type: GrantFiled: March 15, 1991Date of Patent: December 3, 1991Assignee: Ajinomoto Company, Inc.Inventors: Kenichi Yarita, Takahisa Tada, Ryuichiro Kasatani
-
Patent number: 5028622Abstract: A treatment and composition for preventing in mammals the progressive exacerbation of symptoms associated with neurodegenerative disorders characterized by abnormal glutamate metabolism, elevated levels of peripheral glutamate or altered glutamate receptor characteristics. The treatment is comprised of the administration of compositions comprised of amino acids that are effective in retarding the development of symptoms associated with neurodegenerative disorders, presumably by activating the enzyme glutamate dehydrogenase. In the preferred embodiment, the branched chain amino acids L-leucine, L-isoleucine, and L-valine are disclosed as effective therapeutic agents for the treatment of amyotrophic lateral sclerosis.Type: GrantFiled: June 6, 1989Date of Patent: July 2, 1991Assignee: Ajinomoto Company, Inc.Inventor: Andreas Plaitakis
-
Patent number: 4988013Abstract: A container lid structure made essentially of plastics. The lid structure includes a lid frame and a lid plate. The lid plate includes an inner layer comprising a metal foil coated at the opposite sides by plastic layers and connected at the peripheral portion with the lid frame and a core made of a material which is not adhesive to or has a weak bonding power with the plastic material for the lid frame and for the plastic layer of the inner layer. The core is laid over the inner layer with the peripheral portion in an abutting relationship with the inner periphery of the lid frame. A holding member is formed on the core and bonded to the inner layer through apertures in the core. A pulling tab is also formed on the core and bonded to the inner layer through an aperture in the core.Type: GrantFiled: December 22, 1988Date of Patent: January 29, 1991Assignee: Ajinomoto Company, Inc.Inventors: Yukio Kobayashi, Hitoshi Sasaki, Shoji Igota
-
Patent number: 4974458Abstract: An automatic preparation apparatus has turntable means in which a plurality of test tubes can be disposed in radial direction, filter robot means which can move a releasable filter onto one of those test tubes, and probe robot means which can sample the liquid contained within one of the test tubes and inject a predetermined amount of liquid into another one of the test tubes and filter. Furthermore, the apparatus comprises control means for controlling those means in accordance with a predetermined sequence to effect a desired preparation. The probe robot means has a support arm member for supporting the filter.Type: GrantFiled: July 19, 1989Date of Patent: December 4, 1990Assignee: Ajinomoto Company, Inc.Inventor: Toshio Koike
-
Patent number: 4973581Abstract: A new glucan derivative having at least one side chain branch of a compound selected from the group consisting of galactopyranose, L-arabinofuranose and oligomers thereof is disclosed. These glucan derivatives have high tumoricidal activity and are usuable as a tumoricide.Type: GrantFiled: February 20, 1987Date of Patent: November 27, 1990Assignee: Ajinomoto Company, Inc.Inventors: Kei Matsuzaki, Iwao Yamamoto, Akira Misaki, Yoshiaki Sone
-
Patent number: 4956471Abstract: A process for isolating and purifying an amino acid, which comprises subjecting an aqueous solution of said amino acid containing impurities composed mainly of at least one member selected from the group consisting of acidic amino acids, lysine, ornithine, citrulline, histidine, PCA, sulfate ions, chloride ions and pigments to ion-exclusion chromatography using a strongly acidic cation exchange resin.Type: GrantFiled: May 16, 1989Date of Patent: September 11, 1990Assignee: Ajinomoto Company, Inc.Inventors: Hisao Ito, Akio Nishi, Masasi Miyazawa, Masayoshi Naruse